This is a discussion on FDA Panel Rejects REMS for Opioids, Says Current Plan Inadequate within the Other Clinical Pharmacy News forum, part of the Industry News and Updates category; Committee members voted overwhelmingly against the proposal, 25 to 10, saying safety measures are urgently needed, but the current approach ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
|
|||
|
Committee members voted overwhelmingly against the proposal, 25 to 10, saying safety measures are urgently needed, but the current approach doesn't go far enough to protect the public.
Medscape Medical News More... |
![]() |
| Thread Tools | |
| Display Modes | |
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| FDA Releases New REMS Proposal for Opioid Prescription Oversight | industry_news | Other Clinical Pharmacy News | 0 | 06-30-2010 07:28 AM |
| Tapentadol Sometimes Better Tolerated, But Opioids Still First Line | industry_news | Other Clinical Pharmacy News | 0 | 05-20-2010 11:46 AM |
| Risk evalation and Mitigation strategies (REMS) | jibyjoseph | FDA News | 1 | 05-12-2009 03:49 PM |
| Compendia Guiding Off-Label Use of Cancer Drugs Inadequate | industry_news | Other Clinical Pharmacy News | 0 | 02-21-2009 11:13 AM |
| Increased Aspirin or Added Clopidogrel Overcomes Inadequate Platelet Inhibition | industry_news | Other Clinical Pharmacy News | 0 | 09-12-2008 02:29 PM |